(Q28478421)

bacterial drug resistance

20 August 2019

1 reference

People's Republic of China

21 October 2020

0 references

1 reference

Yu Yang

1

Yu

Yang

1 reference

25 October 2023

Xiangwei Li

2

Xiangwei

Li

1 reference

25 October 2023

Feng Zhou

3

Feng

Zhou

1 reference

25 October 2023

Qi Jin

4

Qi

Jin

1 reference

25 October 2023

Lei Gao

5

Lei

Gao

1 reference

Creative Commons Attribution 4.0 International

25 October 2023

language of work or name

English

0 references

publication date

3 June 2011

3 references

23 March 2019

20 August 2019

21 October 2020

3 references

23 March 2019

20 August 2019

21 October 2020

6

0 references

issue

6

0 references

page(s)

e20343

0 references

copyright license

3 references

Europe PubMed Central

23 March 2019

Europe PubMed Central

20 August 2019

Europe PubMed Central

on focus list of Wikimedia project

21 October 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

Global incidence of multidrug-resistant tuberculosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

Measuring inconsistency in meta-analyses

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

The DOTS strategy in China: results and lessons after 10 years

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

High prevalence of drug-resistant tuberculosis and other mycobacteria among HIV-infected patients in Brazil: a systematic review.

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

Management of drug-resistant tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

Epidemiology and challenges to the elimination of global tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

Drug-resistant tuberculosis: a worldwide epidemic poses a new challenge

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

Drug-resistant tuberculosis in Shanghai, China, 2000-2006: prevalence, trends and risk factors.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study

29 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020343

Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. 1944.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

[Report on fourth national epidemiological sampling survey of tuberculosis].

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108589

Prevalence of multidrug and extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study

27 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21674033

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

DOTS in China - removing barriers or moving barriers?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21674033

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0020343

1 reference

ADS bibcode

2011PLoSO...620343Y

0 references

1 reference

1 reference

1 reference